Development of a microcarrier-based cellular expansion technique for the clinical application of human fetal mesenchymal stem cells

In order to derive the maximum potential benefit of stem cell therapy, two of the key challenges are the generation of clinically relevant numbers of cells and the reduction in reliance on serum in cell culture media. This report aims to develop a microcarrier based and serum-free cellular expansion...

Full description

Saved in:
Bibliographic Details
Main Author: Tan, Jun Wen.
Other Authors: School of Chemical and Biomedical Engineering
Format: Final Year Project
Language:English
Published: 2011
Subjects:
Online Access:http://hdl.handle.net/10356/45720
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Nanyang Technological University
Language: English
id sg-ntu-dr.10356-45720
record_format dspace
spelling sg-ntu-dr.10356-457202023-03-03T15:39:34Z Development of a microcarrier-based cellular expansion technique for the clinical application of human fetal mesenchymal stem cells Tan, Jun Wen. School of Chemical and Biomedical Engineering A*STAR Bioprocessing Technology Institute Mayasari Lim DRNTU::Science::Medicine::Tissue engineering In order to derive the maximum potential benefit of stem cell therapy, two of the key challenges are the generation of clinically relevant numbers of cells and the reduction in reliance on serum in cell culture media. This report aims to develop a microcarrier based and serum-free cellular expansion technique for the clinical application of human fetal mesenchymal cells (hfMSC). In this study, a harvesting process involving either Trypsin or Collagenase was investigated for hfMSC on Cytodex 3 microcarriers. A subsequent immunophenotype assay, proliferative potential assay and osteogenic differentiation were performed on harvested cells in order to observe for changes in their characteristics. Cell harvesting was found to be the most effective for 30 and 60 minutes of Trypsin and Collagenase treatment respectively, achieving high cell yield and vitalities near 100%. Although microcarrier expanded cells and monolayer cells have comparable immunophenotypes and proliferative potential, the osteogenic potential of the former was lower than the latter. This study also included a comparison between serum-based D-10 medium and serum-free MesenCult-XF medium. MesenCult-XF medium supported cell growth extensively both in monolayers and on microcarriers, reaching a density of 4.08 x 105 cells/ml on day 8 of microcarrier culture. It also contained lower levels of metabolites during monolayer culture even without medium exchanges. However, it may have caused hfMSC on microcarriers to lose their immunophenotype and also a reduction in osteogenic potential of both microcarrier and monolayer expanded cells. Bachelor of Engineering (Chemical and Biomolecular Engineering) 2011-06-16T07:05:46Z 2011-06-16T07:05:46Z 2011 2011 Final Year Project (FYP) http://hdl.handle.net/10356/45720 en Nanyang Technological University 87 p. application/pdf
institution Nanyang Technological University
building NTU Library
continent Asia
country Singapore
Singapore
content_provider NTU Library
collection DR-NTU
language English
topic DRNTU::Science::Medicine::Tissue engineering
spellingShingle DRNTU::Science::Medicine::Tissue engineering
Tan, Jun Wen.
Development of a microcarrier-based cellular expansion technique for the clinical application of human fetal mesenchymal stem cells
description In order to derive the maximum potential benefit of stem cell therapy, two of the key challenges are the generation of clinically relevant numbers of cells and the reduction in reliance on serum in cell culture media. This report aims to develop a microcarrier based and serum-free cellular expansion technique for the clinical application of human fetal mesenchymal cells (hfMSC). In this study, a harvesting process involving either Trypsin or Collagenase was investigated for hfMSC on Cytodex 3 microcarriers. A subsequent immunophenotype assay, proliferative potential assay and osteogenic differentiation were performed on harvested cells in order to observe for changes in their characteristics. Cell harvesting was found to be the most effective for 30 and 60 minutes of Trypsin and Collagenase treatment respectively, achieving high cell yield and vitalities near 100%. Although microcarrier expanded cells and monolayer cells have comparable immunophenotypes and proliferative potential, the osteogenic potential of the former was lower than the latter. This study also included a comparison between serum-based D-10 medium and serum-free MesenCult-XF medium. MesenCult-XF medium supported cell growth extensively both in monolayers and on microcarriers, reaching a density of 4.08 x 105 cells/ml on day 8 of microcarrier culture. It also contained lower levels of metabolites during monolayer culture even without medium exchanges. However, it may have caused hfMSC on microcarriers to lose their immunophenotype and also a reduction in osteogenic potential of both microcarrier and monolayer expanded cells.
author2 School of Chemical and Biomedical Engineering
author_facet School of Chemical and Biomedical Engineering
Tan, Jun Wen.
format Final Year Project
author Tan, Jun Wen.
author_sort Tan, Jun Wen.
title Development of a microcarrier-based cellular expansion technique for the clinical application of human fetal mesenchymal stem cells
title_short Development of a microcarrier-based cellular expansion technique for the clinical application of human fetal mesenchymal stem cells
title_full Development of a microcarrier-based cellular expansion technique for the clinical application of human fetal mesenchymal stem cells
title_fullStr Development of a microcarrier-based cellular expansion technique for the clinical application of human fetal mesenchymal stem cells
title_full_unstemmed Development of a microcarrier-based cellular expansion technique for the clinical application of human fetal mesenchymal stem cells
title_sort development of a microcarrier-based cellular expansion technique for the clinical application of human fetal mesenchymal stem cells
publishDate 2011
url http://hdl.handle.net/10356/45720
_version_ 1759857350869516288